Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
EMA ASSESSMENT REPORTS |
PORTRAZZA (AUTHORISED: CARCINOMA, NON-SMALL-CELL LUNG)
Created by
admin on Mon Mar 31 20:38:15 GMT 2025 , Edited by admin on Mon Mar 31 20:38:15 GMT 2025
|
||
|
WHO-ATC |
L01XC22
Created by
admin on Mon Mar 31 20:38:15 GMT 2025 , Edited by admin on Mon Mar 31 20:38:15 GMT 2025
|
||
|
NCI_THESAURUS |
C133878
Created by
admin on Mon Mar 31 20:38:15 GMT 2025 , Edited by admin on Mon Mar 31 20:38:15 GMT 2025
|
||
|
NCI_THESAURUS |
C129822
Created by
admin on Mon Mar 31 20:38:15 GMT 2025 , Edited by admin on Mon Mar 31 20:38:15 GMT 2025
|
||
|
NDF-RT |
N0000175664
Created by
admin on Mon Mar 31 20:38:15 GMT 2025 , Edited by admin on Mon Mar 31 20:38:15 GMT 2025
|
||
|
FDA ORPHAN DRUG |
418213
Created by
admin on Mon Mar 31 20:38:15 GMT 2025 , Edited by admin on Mon Mar 31 20:38:15 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
NECITUMUMAB
Created by
admin on Mon Mar 31 20:38:15 GMT 2025 , Edited by admin on Mon Mar 31 20:38:15 GMT 2025
|
PRIMARY | |||
|
100000125948
Created by
admin on Mon Mar 31 20:38:15 GMT 2025 , Edited by admin on Mon Mar 31 20:38:15 GMT 2025
|
PRIMARY | |||
|
SUB33032
Created by
admin on Mon Mar 31 20:38:15 GMT 2025 , Edited by admin on Mon Mar 31 20:38:15 GMT 2025
|
PRIMARY | |||
|
XX-09
Created by
admin on Mon Mar 31 20:38:15 GMT 2025 , Edited by admin on Mon Mar 31 20:38:15 GMT 2025
|
PRIMARY | |||
|
5071
Created by
admin on Mon Mar 31 20:38:15 GMT 2025 , Edited by admin on Mon Mar 31 20:38:15 GMT 2025
|
PRIMARY | |||
|
DB09559
Created by
admin on Mon Mar 31 20:38:15 GMT 2025 , Edited by admin on Mon Mar 31 20:38:15 GMT 2025
|
PRIMARY | |||
|
2BT4C47RUI
Created by
admin on Mon Mar 31 20:38:15 GMT 2025 , Edited by admin on Mon Mar 31 20:38:15 GMT 2025
|
PRIMARY | |||
|
2BT4C47RUI
Created by
admin on Mon Mar 31 20:38:15 GMT 2025 , Edited by admin on Mon Mar 31 20:38:15 GMT 2025
|
PRIMARY | |||
|
C88281
Created by
admin on Mon Mar 31 20:38:15 GMT 2025 , Edited by admin on Mon Mar 31 20:38:15 GMT 2025
|
PRIMARY | |||
|
Necitumumab
Created by
admin on Mon Mar 31 20:38:15 GMT 2025 , Edited by admin on Mon Mar 31 20:38:15 GMT 2025
|
PRIMARY | |||
|
m7790
Created by
admin on Mon Mar 31 20:38:15 GMT 2025 , Edited by admin on Mon Mar 31 20:38:15 GMT 2025
|
PRIMARY | Merck Index | ||
|
1723738
Created by
admin on Mon Mar 31 20:38:15 GMT 2025 , Edited by admin on Mon Mar 31 20:38:15 GMT 2025
|
PRIMARY | RxNorm | ||
|
906805-06-9
Created by
admin on Mon Mar 31 20:38:15 GMT 2025 , Edited by admin on Mon Mar 31 20:38:15 GMT 2025
|
PRIMARY | |||
|
CHEMBL1743047
Created by
admin on Mon Mar 31 20:38:15 GMT 2025 , Edited by admin on Mon Mar 31 20:38:15 GMT 2025
|
PRIMARY | |||
|
9083
Created by
admin on Mon Mar 31 20:38:15 GMT 2025 , Edited by admin on Mon Mar 31 20:38:15 GMT 2025
|
PRIMARY |
ACTIVE MOIETY